VS

Vasanthi Sirisha Mutchumari

Active Director Director DIN 10916334
DIN 10916334 First appointment Feb 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vasanthi Sirisha Mutchumari

Data last updated:

Vasanthi Sirisha Mutchumari is a Director at Manikonda Reddy Foundation (since 2025) and Director at Ramsun Pharma Private Limited (since 2025).

DIN 10916334
Primary Designation Director
First Appointment 27 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Manikonda Reddy Foundation U88900TS2025NPL196161
Director27 Mar 20252025Active
Ramsun Pharma Private Limited U46497TS2025PTC194753
Director27 Feb 20252025Active

Board colleagues of Vasanthi Sirisha Mutchumari

Directorship timeline

Open interactive timeline →
Ramsun Pharma Private Limited
Manikonda Reddy Foundation
Premium access

Shareholding and investment profile for Vasanthi Sirisha Mutchumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vasanthi Sirisha Mutchumari

Vasanthi Sirisha Mutchumari currently holds 2 directorships: Manikonda Reddy Foundation (Director, since 27 Mar 2025); Ramsun Pharma Private Limited (Director, since 27 Feb 2025).

Vasanthi Sirisha Mutchumari was first appointed on 27 Feb 2025 as Director at Ramsun Pharma Private Limited.

The current boards of Vasanthi Sirisha Mutchumari's companies include Rama Subba Reddy Sanikommu (Manikonda Reddy Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available